{"id":"W2787639107","doi":"10.1177/1758834017753338","title":"Turning <i>EGFR</i> mutation-positive non-small-cell lung cancer into a chronic disease: optimal sequential therapy with EGFR tyrosine kinase inhibitors","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Medical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Osimertinib; Afatinib; Erlotinib; T790M; Gefitinib; Medicine; Lung cancer; Tolerability; Oncology; Epidermal growth factor receptor; Resistance mutation; Erlotinib Hydrochloride; Tyrosine kinase; Internal medicine; Cancer research; Cancer; Adverse effect; Biology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003921209,0.000822022,0.002233685,0.0003318647,0.0002112954,0.00002951183,0.0003735055,0.0006069875,0.0007450487],"category_scores_gemma":[0.0000447819,0.0005453292,0.0003545335,0.00073641,0.0008890207,0.0002057144,0.00009502919,0.001158749,0.00002788826],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.004168615,"about_ca_system_score_gemma":0.01122561,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001811741,"about_ca_topic_score_gemma":0.0003914783,"domain_scores_codex":[0.9959675,0.0004148918,0.001035516,0.001016451,0.0007808041,0.0007848272],"domain_scores_gemma":[0.997436,0.0005661382,0.0006824233,0.0004582884,0.0002214889,0.0006356897],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007131051,0.000882659,0.0001247587,0.005770374,0.0009787729,0.001742103,0.001086626,0.00009645279,0.00000548786,0.00004390132,0.0001124155,0.9884433],"study_design_scores_gemma":[0.008598335,0.003220296,0.00003599906,0.02319677,0.004572718,0.0002084699,0.0001388114,0.0005323614,0.00003558253,0.00005840915,0.9587455,0.0006567627],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004797831,0.990311,0.003011556,0.0008537396,0.001117218,0.003126774,0.0000587326,0.00008082088,0.0009603242],"genre_scores_gemma":[0.001650373,0.9901529,0.001275384,0.001326833,0.002052082,0.002371692,0.0005819434,0.0001598255,0.0004289596],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9877866,"threshold_uncertainty_score":0.9996998,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0187632283556493,"score_gpt":0.4154327985471971,"score_spread":0.3966695701915478,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}